- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05264090
Possibilities of Interpreting the Night-to-Day Ratio Specified by 24-hour Blood Pressure Monitoring (ABPM)
Seven-day Ambulatory Blood Pressure Monitoring and CAVI in the Prevention of Cardiovascular Diseases
Study Overview
Status
Conditions
Detailed Description
The subjects in the study are divided into 4 groups:
group 1 (40 healthy men and women without exercise); group 2 (40 healthy exercise-training men and women); group 3 (40 patients with ischemic coronary artery disease without exercise); and group 4 (51 patients with ischemic coronary artery disease following cardiovascular rehabilitation).
The subject of the evaluation is the percentage rate of incorrect subject classification (dipper, non-dipper, extreme dipper, and risers) based on the mean blood pressure values for 7 days and from seven independent 24-hour cycles (the mean value mode).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brno, Czechia, 654 91
- St. Anne´s University Hospital Brno
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy volunteers (without any disease, including the cardiovascular ones, and without any kind of treatment)
- Patients with chronic ischemic coronary artery disease
- Patients treated with ACE inhibitors, beta-blockers or statins.
- To visit routinely in the health centres where the study is carried out
Exclusion Criteria:
- Age under 18 years,
- Pregnant, or breast-feeding,
- Patients on dialysis or being followed by nephrology,
- Severe physical or cognitive limitations,
- Intolerance to the method of measurement
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Group 1
Healthy volunteers without exercise
|
The ambulatory monitoring (7-day ABPM) was performed with ambulatory blood pressure monitoring devices TM-2430 (A&D; Tokyo, Japan) based on both the cuff-oscillometric and Korotkoff sound method.
The cuff was placed on the non-dominant arm according to the same rules applying to casual auscultation measurement.
The monitoring device with a weight of 250 g was worn by the monitored subjects in a waist-fixed case continuously for 7 days except for times involving personal hygiene.
During every automatic measurement, the arm was resting and hung along the body.
The device automatically recorded all the regular measurements for seven days, between 6:00 a.m. and 10:00 p.m. every 30 minutes and between 10:00 p.m. and 6:00 a.m.
every 60 minutes.
Such short intervals are necessary to obtain a sufficient number of representative measurements.
|
|
Sham Comparator: Group 2
Healthy exercise-training volunteers
|
The ambulatory monitoring (7-day ABPM) was performed with ambulatory blood pressure monitoring devices TM-2430 (A&D; Tokyo, Japan) based on both the cuff-oscillometric and Korotkoff sound method.
The cuff was placed on the non-dominant arm according to the same rules applying to casual auscultation measurement.
The monitoring device with a weight of 250 g was worn by the monitored subjects in a waist-fixed case continuously for 7 days except for times involving personal hygiene.
During every automatic measurement, the arm was resting and hung along the body.
The device automatically recorded all the regular measurements for seven days, between 6:00 a.m. and 10:00 p.m. every 30 minutes and between 10:00 p.m. and 6:00 a.m.
every 60 minutes.
Such short intervals are necessary to obtain a sufficient number of representative measurements.
Combined aerobic-resistance exercise (group 2) was scheduled twice weekly in the form of 60-minute workouts with a load intensity at the level of sub-maximum heart frequency (75-85% SFmax).
The minimum time span between the workouts was 24 hours.
The workout consisted of a 10-minute warm-up, 25 minutes of aerobic exercise (spinning bicycle or bicycle ergometer), 15 minutes of resistance exercise on gym machines (bench press, leg extension and pull down) with 40-50% 1-RM (one repetition maximum) intensity (3 series of 10 exercises), and a 10-minute cool-down (stretching of the main muscle groups).
|
|
Active Comparator: Group 3
Patients with ischemic coronary artery disease without exercise
|
The ambulatory monitoring (7-day ABPM) was performed with ambulatory blood pressure monitoring devices TM-2430 (A&D; Tokyo, Japan) based on both the cuff-oscillometric and Korotkoff sound method.
The cuff was placed on the non-dominant arm according to the same rules applying to casual auscultation measurement.
The monitoring device with a weight of 250 g was worn by the monitored subjects in a waist-fixed case continuously for 7 days except for times involving personal hygiene.
During every automatic measurement, the arm was resting and hung along the body.
The device automatically recorded all the regular measurements for seven days, between 6:00 a.m. and 10:00 p.m. every 30 minutes and between 10:00 p.m. and 6:00 a.m.
every 60 minutes.
Such short intervals are necessary to obtain a sufficient number of representative measurements.
|
|
Experimental: Group 4
Patients with ischemic coronary artery disease following cardiovascular rehabilitation
|
The ambulatory monitoring (7-day ABPM) was performed with ambulatory blood pressure monitoring devices TM-2430 (A&D; Tokyo, Japan) based on both the cuff-oscillometric and Korotkoff sound method.
The cuff was placed on the non-dominant arm according to the same rules applying to casual auscultation measurement.
The monitoring device with a weight of 250 g was worn by the monitored subjects in a waist-fixed case continuously for 7 days except for times involving personal hygiene.
During every automatic measurement, the arm was resting and hung along the body.
The device automatically recorded all the regular measurements for seven days, between 6:00 a.m. and 10:00 p.m. every 30 minutes and between 10:00 p.m. and 6:00 a.m.
every 60 minutes.
Such short intervals are necessary to obtain a sufficient number of representative measurements.
The cardiovascular exercise (group 4) took the form of sixty-minute workouts scheduled two to three times weekly.
The nature of the workouts was similar, combined aerobic-resistance exercise (a 10-minute warm-up, aerobic endurance on bicycle ergo meter for 25 minutes, resistance exercise on multifunctional gym machines for 15 minutes, and a 10-minute cool-down).
The workout intensity was set at the level of the first ventilation threshold (VAT-1), corresponding to the following workout parameters: load (W) and heart rate (HR).19,20
The resistance exercise intensity was specified by the 1-RM (one repetition maximum) method.
The maximum load lifted across the full range of motion for every exercise was used as the benchmark for the workload intensity specification, corresponding to 30 - 60% 1-RM.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The risk rate of incorrect patient classification based on night-to-day ratio specification from singular 24-h ABPM in comparison to the results of 7-day ABPM monitoring.
Time Frame: 1 - 7 days
|
Primary outcome was to specify the risk rate of incorrect patient classification based on night-to-day ratio specification from singular 24-h ABPM in comparison to the results of 7-day ABPM monitoring. The percentage of blood pressure drop at night expressed by night-to-day ratio (dippers, non-dippers, extreme dippers, reverse dippers) can be specified much more accurately on the basis of 7-day ABPM values. ABPM restricted to 24 h, as currently practiced, does not yield a sufficiently reliable estimate of the night-to-day ratio for a classification in terms of dipping. Extending monitoring to 7 days accounts for the large day-to-day variability in the night-to-day ratio, and may yield a more reliable diagnosis of blood pressure variability. |
1 - 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Optimalization of the blood pressure diagnostic through comparing of 24 hours and 7 days monitoring.
Time Frame: 1 - 7 days
|
On the basis of the obtained results, the following procedure can be recommended for clinical practice. If the standard 24-hour monitoring is used, then obtain at least 3 mutually independent 24-hour cycle data for every examined individual. If at least two of them result in the same night-to-day ratio and the third night-to-day ratio is only slightly different, the thus obtained index can be considered trustworthy. Otherwise, the correct night-to-day ratio can only be obtained by 7-day ABPM and, in addition, the resulting night-to-day ratio calculated from the mean values obtained in the course of the 7 days must be compared to the result modes obtained for the individual monitoring days. The magnitude of the difference between the evaluation of 24-hour and 7-days blood pressure records was not dependent on the gender, age, health, or cardiovascular disease or physical activity of monitored individuals. |
1 - 7 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24H7D_ABPM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Ambulatory blood pressure monitoring
-
University of MichiganCompletedHypertensionUnited States
-
University of AarhusCompleted
-
General Administration of Military Health, TunisiaRecruiting
-
Yokohama City University Medical CenterCompletedDiabetes Mellitus | Renal Failure | Essential Hypertension | Chronic NephropathyJapan
-
Italian Institute of TelemedicineItalian Society of Hypertension; Italian Society of General Practitioners; Biotechmed...Recruiting
-
Italian Institute of TelemedicineBPLabCompletedHypertensionRussian Federation, Argentina, Armenia, Australia, Italy, Kazakhstan, Mexico, Portugal, Romania, Ukraine
-
University of VigoUniversity of California, Los Angeles; National Institute on Minority Health... and other collaboratorsCompleted
-
Seoul National University HospitalKangbuk Samsung Hospital; Severance Hospital; Eulji General HospitalUnknownHypertension | Chronic Kidney Diseases | Renal Insufficiency, Chronic | AlbuminuriaKorea, Republic of
-
Arkansas Children's Hospital Research InstitutePediatric Pharmacology Research Units NetworkCompleted
-
Shanghai 10th People's HospitalUnknown